Serum levels of aminoterminal propeptides of type I collagen indicating osteoporsis in early postmenopausal women with correlation to bone densitometry
New Egyptian Journal of Medicine [The]. 2002; 26 (Supp. 2): 7-9
in English
| IMEMR
| ID: emr-60234
ABSTRACT
To reduce accelerated bone loss in early postmenopause and to minimize the risk of fracture, a variety of antiresorptive treatments [e.g. calcium, calcitonin, estrogen and bisphosphonates] was used. Among the different bone resorption markers, degradation products of type I collagen have demonstrated their superiority. The serum levels of aminoterminal propeptides [PINP] of type I collagen were determined in the sera of 60 healthy postmenopausal women subjected to densitometric measurements of lumber vertebrae to indicate osteoporosis. Bone mineral densitometry [BMD] was most strongly associated with the serum levels of propeptides type I collagen. The value of PINP may be used as an indicator not only for the treatment evaluation but also as a predictor of the risk of occurrence of hip or spine bone fractures
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Bone Density
/
Collagen
Limits:
Female
/
Humans
Language:
English
Journal:
New Egypt. J. Med.
Year:
2002
Similar
MEDLINE
...
LILACS
LIS